Celltrion Healthcare to Supply Remsima to the Brazilian Federal Government
Shots:
- Celltrion’s biosimilar Remsima has won a tender by the Brazilian Federal Government along with 12 state bids to supply Remsima including in Sao Paulo, following the Aug 2021 agreement with the Ministry of Health for 2 anticancer drugs, Herzuma & Truxima
- The company also won a tender offer by INSABI for the purchase of Truxima for 1yr. & will supply Remsima to private sector, federal & State government
- The company broadens patient access to effective & affordable biosimilar therapy in Brazil & Mexico, strengthening & expand its presence in Latin America. The company also established an entity in Brazil & Mexico to manage sales & marketing activities for biosimilar products
Ref: Celltrion | Image: Celltrion
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
